Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
Author(s) -
Paloma Jordà,
Ana GarcíaÁlvarez
Publication year - 2018
Publication title -
global cardiology science and practice
Language(s) - English
Resource type - Journals
ISSN - 2305-7823
DOI - 10.21542/gcsp.2018.25
Subject(s) - hypertrophic cardiomyopathy , medicine , asymptomatic , sudden cardiac death , risk stratification , disease , cardiology , sudden death , cardiomyopathy , heart failure
[first paragraph of article] Sudden cardiac death (SCD) is a devastating and often unpredictable complication of hypertrophic cardiomyopathy (HCM) that may occur as the initial disease presentation, frequently in asymptomatic or mildly symptomatic young people. Until 2000, only small series of patients examining predictors of SCD had been published, with a selection bias towards severe disease. Subsequently, larger series that are more representative of the HCM spectrum have shown that the annual SCD rate is less than 1% , and that there are subgroups of patients with a clearly higher risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom